Skip to content

Mirion Technologies MIR Medical Segment — Measurement period adjustment

Other segment segments

Nuclear & Safety
-$2.4M

Similar metrics at other companies

Medline, Inc.
 logo
MDLNMedline Brand — Measurement period adjustments
$1M
California Resources logo
CRCMeasurement period adjustments, net
$0-100%
GitLab logo
GTLBAcquisition measurement period adjustment
$0-100%
WEX logo
WEXMobility — Measurement period adjustments
$0+100%
Welltower logo
WELLOutpatient Medical — Acquisition measurement period adjustments
$0
IDEX logo
IEXFire & Safety/Diversified Products — Measurement period adjustments
$0

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's medical segment — measurement period adjustment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's medical segment — measurement period adjustment?
Mirion Technologies (MIR) reported medical segment — measurement period adjustment of $0 in Q1 2026.
What does medical segment — measurement period adjustment mean?
Reflects adjustments made to the provisional fair values of assets acquired and liabilities assumed during the measurement period following an acquisition within the Medical segment. These adjustments occur when new information is obtained about facts and circumstances that existed as of the acquisition date. It serves as a indicator of the precision of initial purchase price allocations for the segment's growth initiatives.